logo
Cecabank and Bit2Me Ready to Launch Their Comprehensive Digital Asset Solution for Traditional and Digital Banks

Cecabank and Bit2Me Ready to Launch Their Comprehensive Digital Asset Solution for Traditional and Digital Banks

Bit2Me and Cecabank are launching a comprehensive digital asset solution designed specifically for the banking sector.
The new solution offers banks real-time access to cryptocurrency market data, secure fund custody, and a trading platform with over 100 digital assets.
Cecabank is a leading custodian bank in Europe, managing over €350 billion in assets under custody as of 2024, with international coverage. In May 2024, the bank entered into a strategic alliance with Bit2Me to jointly develop solutions that accelerate digital asset adoption across financial institutions. The platform is now ready to go live.
MADRID, May 26, 2025 /PRNewswire/ — Bit2Me, Spain's leading cryptocurrency platform and a major player in Europe, and Cecabank, a top-tier custodian bank on the Iberian Peninsula, announce the launch of a fully integrated digital asset solution tailored for traditional financial institutions. This new offering enables banks to deliver crypto services quickly, securely, and in alignment with the legal clarity and oversight provided by Europe's MiCA (Markets in Crypto-Assets) regulation.
The platform gives both traditional and digital banks access to crypto services, including custody and RTO (Reception and Transmission of Orders). Bit2Me oversees the trading operations, offering real-time market data, secure cold-wallet custody, and a platform supporting the buying, selling, and exchanging of over 100 cryptocurrencies—with customizable options and high liquidity.
Cecabank brings decades of experience in banking services, regulatory expertise, a robust technical infrastructure, and strong risk management capabilities. Its collaboration with Bit2Me—known for its transparency, resilience, and regulatory compliance—bridges the gap between traditional and digital finance, reinforcing trust in digital financial services.
The platform is fully integrated and technically ready, pending regulatory authorization from the CNMV (Spanish Securities Market Commission) for participating market entities.
Aurora Cuadros, Head of Securities Services at Cecabank, states: 'With this alliance, Cecabank strengthens its roadmap as a reference provider of post-trade services in the digital asset space, reflecting our established role in FIAT custody.'
The Future of Digital Assets in the Institutional Space
Major banks and institutions are increasingly exploring digital assets to integrate traditional and digital currencies into their offerings. Leif Ferreira, CEO and Co-Founder of Bit2Me, notes: '2025 marks a turning point for banks to begin offering crypto trading services.' Abel Peña, Chief Sales Officer at Bit2Me, adds: 'Traditional banking is playing a transformative role in the mainstream adoption of digital assets.'
Regulatory frameworks like MiCA are driving legal clarity and promoting integration between crypto platforms and traditional financial markets. Strategic initiatives such as the Bit2Me–Cecabank partnership will be key to delivering innovative financial products tailored to today's evolving financial landscape.
DisclaimerInvestment in crypto assets is not fully regulated, may not be suitable for retail investors due to their high volatility, and there is a risk of losing the entire invested amount.
Media Contact:Bit2Me Communications Departmentpr@bit2me.com
Photo – https://mma.prnewswire.com/media/2695134/Bit2Me_Cecabank.jpgLogo – https://mma.prnewswire.com/media/2695135/Bit2Me_Logo.jpg

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

DMRC Deadline: DMRC Investors with Losses in Excess of $100K Have Opportunity to Lead Digimarc Corporation Securities Fraud Lawsuit
DMRC Deadline: DMRC Investors with Losses in Excess of $100K Have Opportunity to Lead Digimarc Corporation Securities Fraud Lawsuit

Malaysian Reserve

time39 minutes ago

  • Malaysian Reserve

DMRC Deadline: DMRC Investors with Losses in Excess of $100K Have Opportunity to Lead Digimarc Corporation Securities Fraud Lawsuit

NEW YORK , June 13, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Digimarc Corporation (NASDAQ: DMRC) between May 3, 2024 and February 26, 2025, both dates inclusive (the 'Class Period'), of the important July 8, 2025 lead plaintiff deadline. So what: If you purchased Digimarc securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the Digimarc class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email case@ for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 8, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) a large commercial partner would not renew a large contract on the same terms; (2) as a result, Digimarc would renegotiate the large commercial contract; (3) as a result of the foregoing, Digimarc's subscription revenue and annual recurring revenue would be adversely affected; and (4) as a result of the foregoing, defendants' positive statements about Digimarc's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Digimarc class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email case@ for more information. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Kim, Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) 202-3827case@

Billions in Deals Reshaping the Cell and Gene Therapy Industry, reports Kalorama Information
Billions in Deals Reshaping the Cell and Gene Therapy Industry, reports Kalorama Information

Malaysian Reserve

time2 hours ago

  • Malaysian Reserve

Billions in Deals Reshaping the Cell and Gene Therapy Industry, reports Kalorama Information

ARLINGTON, Va., June 13, 2025 /PRNewswire/ — Kalorama Information, a leading publisher of life sciences market research, has released the highly anticipated third edition of its landmark report, Cell and Gene Therapy Market Deals: Investments, M&As, and Partnerships, 2021–2025. This comprehensive analysis offers an in-depth look at the financial ecosystem fueling the explosive growth of the cell and gene therapy (CGT) industry — a market defined by breakthrough innovation, global competition, and evolving funding landscapes. The report is released in two installments, with the first part available now, covering deals through Q4 2024. The second installment, included with purchase, will be released in Fall 2025 and cover activity through Q3 2025. 'Many categories of deals, such as collaborations, distribution/co-marketing, and manufacturing/supply chain, have shown a long-term pattern of growth,' said Justin Saeks, senior market analyst at Kalorama Information. 'And there's reason for optimism regarding continued investments. Cell and gene therapy-related companies have continued to receive huge amounts of investment.' Key Insights from the Report: Over 2,000 CGT-related deals analyzed, with quarterly trends tracked from Q1 2021 to Q4 2024 Despite a tighter funding environment, 2024 investment reached an estimated $39 billion, with a sharp Q4 uptick Top dealmakers include Astellas, Bristol Myers Squibb, Ginkgo Bioworks, Charles River, and Eli Lilly Deal types covered: VC/PE, IPO/SPAC, licensing, tech transfer, acquisitions, supply chain partnerships, and more Global perspective includes detailed breakdowns by region — North America, Europe, and APAC Why This Matters Now The CGT market is maturing fast, with fluctuating investment trends, growing deal diversity, and strategic partnerships becoming essential to survival. In 2023 and 2024, firms faced a contraction in available capital — from $73 billion in 2021 down to $35 billion in 2023 — yet collaborative and manufacturing partnerships have been on the rise. This suggests that dealmaking is evolving, not disappearing. Who Should Purchase and Read This Report This report is essential for: Biotech and pharma execs seeking M&A or licensing opportunities VC/PE investors tracking funding cycles and active biotech targets Strategic planners and BD professionals looking to benchmark activity Consultants, CROs, and CMOs aligning services with market needs Regulatory and policy advisors assessing funding shifts and regional dynamics Strategic Use Cases Identify high-activity players and ideal partners for collaboration or acquisition Benchmark funding rounds and valuations for startups or expanding companies Inform R&D focus by tracking which technologies (e.g., CRISPR, AAV) are attracting deals Support global expansion using regional deal patterns and emerging market trends Strengthen regulatory preparedness by understanding the impact of policy shifts on financing Companion Report Available This report pairs with Kalorama's Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 2024–2030 (4th Edition) — offering disease-area breakdowns of the CGT landscape in oncology, neurology, musculoskeletal, and beyond. Get the Report Download or purchase the report here:Cell and Gene Therapy Market Deals: Investments, M&As, and Partnerships, 2021–2025 (3rd Edition) Explore the companion report:Cell and Gene Therapy Market Dynamics by Disease Type, 2024–2030 (4th Edition) About Kalorama InformationKalorama Information, part of Science and Medicine Group, is a trusted source of market research in the life sciences. With a focus on in vitro diagnostics, biotechnology, and medical devices, Kalorama reports are used by top healthcare companies, government agencies, and investment firms worldwide. For purchase or custom consultation, contact:Sheri DavieKalorama Information Sales For media inquiries please contact:Alisa AlvichMarketing

Kathy Bloomgarden Wins PR Agency Leader at Campaign Agency of the Year Global Awards
Kathy Bloomgarden Wins PR Agency Leader at Campaign Agency of the Year Global Awards

Malaysian Reserve

time3 hours ago

  • Malaysian Reserve

Kathy Bloomgarden Wins PR Agency Leader at Campaign Agency of the Year Global Awards

NEW YORK, June 13, 2025 /PRNewswire/ — Dr. Kathy Bloomgarden, CEO of Ruder Finn, was awarded Agency Leader in the PR, Marketing, and Communications category at this year's Campaign Agency of the Year Global Awards. Campaign Global recognized Bloomgarden for her leadership in emerging technologies and artificial intelligence driven communications, and for driving 8% growth for the agency in 2024, contributing to a remarkable 140% increase over the past five years. Bloomgarden has been at the helm of Ruder Finn as CEO since 2014. Under her leadership, Ruder Finn has reached many new frontiers, including launching the agency's China office, healthcare practice, and technology innovation hub Bloomgarden has driven industry-leading growth and global expansion, pioneering the adoption of disruptive technologies. She has been at the forefront of AI strategies, shaping AI-ready data infrastructures, addressing LLM hallucinations, and bridging east-west divides in AI development. Within the past year, Bloomgarden established the RF AI Advisory Council and spearheaded the agency's newest LLM optimization offering She convenes high-level dialogues on tech disruption and is a trusted voice in global leadership circles, including the World Economic Forum and Fortune's CEO Council. With her ability to anticipate trends and act decisively, Bloomgarden has made Ruder Finn a key partner for global clients navigating economic uncertainties, geopolitical tension, and technological disruption. 'It is an honor to receive this prestigious honor from Campaign Global,' said Bloomgarden. 'We are at a transformative juncture for our industry, where the role of communications is crucial in driving the adoption of groundbreaking technologies on a global scale across industries. I am profoundly optimistic about our collective ability to work together, and for communications change-makers to fast-track innovation and create significant change.' This year's Campaign Agency of the Year Global Awards were held in London on June 12th, 2025. About Ruder Finn Ruder Finn is one of the world's largest independent global communications and integrated marketing agencies, leading the industry in AI strategy and implementation. Founded in 1948, Ruder Finn has defined and redefined PR for over 75 years, shaping communications that moves industry-defining brands, companies, and leaders from what's now to what's next. Ruder Finn provides clients with bold strategies based on a global perspective and localized market knowledge that redefine leadership, reimagine the marketplace, and rethink customer experiences. The agency is organized around five core areas of expertise—Healthcare, Technology, Consumer Brand, Leadership and Workplace—with innovative tech incubator RF TechLab providing cutting-edge predictive analytics, AI-powered creative hub RF Studio53 offering breakthrough creative, and specialized teams delivering customer-focused digital engagement. Ruder Finn has offices across four continents including the U.S., Asia, Europe and the Middle East. Wholly owned agencies and offerings within Ruder Finn Group include: Ruder Finn Inc., RF Studio53, RF Engage, Touchdown, Peppercomm, RF Comunicad, Mantis, jacobstahl, Flightpath, Ruder Finn Atteline, Pandan Social, RF Bloom, and Big Sky Communications. For more information visit Media Contact: Isabelle Lee,

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store